5.10% p.a. Early Redemption Worst of GOAL

Underlying: Biogen Idec / Novo Nordisk / Shire SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 41051278 / ISIN: CH0410512781

Last update 20.07.2018
  • Bid

    100.87 %
    Volume: 10'000

  • Ask

    101.87 %
    Volume: 10'000